LCI logo

LCI Lannett Company, Inc.

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$0.69
+0.00 (+0.00%)

Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to the comprehensive process of developing, manufacturing, packaging, commercializing, and distributing generic versions of established brand-name drugs. Its extensive product portfolio encompasses a wide array of dosage forms, including solid oral, extended-release, topical, liquid, nasal, ophthalmic, injectable, patch, …

Market Cap: $7.38Mwww.lannett.com

Price

No data yet.

Social Signal Score

46
5d
50
1 mentions
—
30d
45
4 mentions
—
60d
45
4 mentions
—
90d
45
4 mentions
—
news: 4

Analyst Ratings

1 analyst
Buyconsensus
Strong Buy 0Buy 1Hold 0Sell 0Strong Sell 0

Revenue

$80.51M+100.40%
$40.17M$91.36M$142.54M$193.72M
Jun 2013Mar 2023

Company Profile

CEO
Timothy C. Crew
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
564
Beta
0.95
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-5.79
www.lannett.com